# ZALTRAP

NDC: 0024-5841
Generic name: ziv-aflibercept
Labeler / Manufacturer: sanofi-aventis U.S. LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20120803

FDA application: BLA125418

## Active ingredients

- AFLIBERCEPT: 200 mg/8mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0024-5841"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0024-5841
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f6725df6-50ee-4b0a-b900-d02ba634395d